Bharat Book

Lyme Disease - Pipeline Review, H2 2013

Press Release   •   Dec 06, 2013 10:03 IST

Dec 06, 2013 : Bharat Book Bureau presents the new report, on 'Lyme Disease - Pipeline Review, H2 2013'  reviews key players involved in the therapeutic development for Lyme Disease. Lyme Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- A snapshot of the global therapeutic scenario for Lyme Disease.
- A review of the Lyme Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Lyme Disease pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Lyme Disease.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Lyme Disease pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned

Baxter International Inc.
Zosano Pharma, Inc.
Viral Genetics, Inc.

Table of contents :

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Lyme Disease Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Lyme Disease 7
Lyme Disease Therapeutics under Development by Companies 9
Lyme Disease Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Early Clinical Stage Products 12
Comparative Analysis 12
Discovery and Pre-Clinical Stage Products 13
Comparative Analysis 13
Lyme Disease Therapeutics - Products under Development by Companies 14
Lyme Disease Therapeutics - Products under Investigation by Universities/Institutes 15
Companies Involved in Lyme Disease Therapeutics Development 16
Baxter International Inc. 16
Zosano Pharma, Inc. 17
Viral Genetics, Inc. 18
Lyme Disease - Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Route of Administration 20
Assessment by Molecule Type 22
Drug Profiles 24
IC-15 - Drug Profile 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Isac - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
VGV-L - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Lyme Disease Vaccine - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
azithromycin gel - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Multicomponent Lyme Vaccine - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
doxorubicin Nanosphere - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Lyme Disease Therapeutics - Drug Profile Updates 31
Lyme Disease Therapeutics - Dormant Products 32
Lyme Disease - Product Development Milestones 33
Featured News & Press Releases 33
Mar 07, 2012: Viral Genetics Submits Pre-IND Document For Lyme Disease Drug Candidate To FDA 33
Oct 21, 2008: Viral Genetics, Inc. Releases Initial Findings of Lyme Disease Study and Team Receives Positive Feedback at ILADS Conference, Study Model Potentially Applies to HIV/AIDS and Other Immune Based Diseases. 34
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 35
Contact Us 36
Disclaimer 36

For more information kindly visit :

Related link :

About Bharat Book Bureau:

Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don't match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.

Contact us at : s

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Follow us on twitter: 
Follow us on linked in : 
Our Blog : 

Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.